Defended June 9, Defended May 28, Defended March 7, Impact of adjuvant radiotherapy to the internal mammary lymph nodes in the treatment of early lymph node metastasizing breast cancer. Defended October 26,
University of Southern Denmark. Defended June 4, Dynamic multileaf collimator tracking and dose delivery for moving targets in radiotherapy. Biomedical Engineering, University of Aarhus, October Recurrence location after definitive chemo radiation therapy for head and neck squamos cell carcinoma in relation to clinical target volumes and 18F -FDG uptake. Investigation of dosimetric and radiobiological models for particle therapy.
Defended June 14, Image based motion monitoring during stereotactic body radiotherapy at a conventional linear accelerator.
Characterization of target motion during radiotherapy of lung cancer. Defended April 16, Defended December 21, Defended June 13, thhesis Intrinsic radiation resistance of mesenchymal cancer stem cells and implications for treatment response in a murine sarcoma model.
The role of Human papillomavirus in head and neck cancer and the impact on radiotherapy outcome.
Organ Motion — 4D imaging and treatment. Defended June 28, Defended March 19, Defended December 9, Resistance training and dietary supplements as intervention for regaining muscle mass following radiotherapy in head and neck cancer patients.
Defended April 4, Defended August 27, Defended May 30, Recurrence location after definitive chemo radiation therapy for head and neck squamos cell carcinoma in relation to clinical target volumes and 18F -FDG uptake.
Home News Research Publications People. Defended October 10, Defended May 27, Novel dosimetry methods in heavy charged particle beams.
University of Southern Denmark. Image guided radiotherapy in cervical cancer.
Defended June 24, Defended August 25, Defended August 15, Evaluation and optimization of modern treatment planning and treatment techniques. Defended November 27, Importance of follow-up after treatment for head and neck cancer.
CIRRO – PhD and Master’s Theses
Nimorazole as hypoxic radiosensitizer in radiotherapy for head and neck cancer. Defended October 9, Defended February 24, Defended Vvmat 18, Defended October 30, Long-term follow-up after modern radical prostate cancer radiotherapy – exploring the use of MRI delineation and a NI-TI stent as fiducial marker. Defended February 27,